Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 208 participants.

Also called NCT02526875

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 208 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02526875
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02526875. Randomized; no masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2017-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled
Condition
Hypertension
Intervention (Drug)
Telminuvo®Tab. 40/2.5mg
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct02526875
Content hash
6a52382c2f95ebccce6dee24f68bc4b65a243daaace2750500b7f1e151a59a9d